Biblio

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

G

Rostami M, Haidari K, Amini H, Shahbazi M. Genetically Engineered Mesenchymal Stem Cell Therapy Against Murine Experimental Autoimmune Encephalomyelitis. Mol Neurobiol. 2022.

Hwang BWoo, Kim SJin, Park KMin, Kim H, Yeom J, Yang J-A, Jeong H, Jung H, Kim K, Sung YChul, et al. Genetically engineered mesenchymal stem cell therapy using self-assembling supramolecular hydrogels. J Control Release. 2015.

Huang H, Qian M, Liu Y, Chen S, Li H, Han Z, Han Z-C, Chen X, Zhao Q, Li Z. Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy. Elife. 2023;12.

Li J, Li N, Wei J, Feng C, Chen Y, Chen T, Ai Z, Zhu X, Ji W, Li T. Genetically engineered mesenchymal stem cells with dopamine synthesis for Parkinson's disease in animal models. NPJ Parkinsons Dis. 2022;8(1):175.

Mahmoudian RAlsadat, Farshchian M, Abbaszadegan MReza. Genetically Engineered Mouse Models of Esophageal Cancer. Exp Cell Res. 2021:112757.

Kaczanowska S, Beury DW, Gopalan V, Tycko AK, Qin H, Clements ME, Drake J, Nwanze C, Murgai M, Rae Z, et al. Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis. Cell. 2021.

Ismaeel GLutfi, AlHassani OJabbar Mak, Alazragi RS, Ahmed AHussein, Mohamed A'aH, Jasim NYasir, Shari FHassan, Almashhadani HAbdulkaree. Genetically engineered neural stem cells (NSCs) therapy for neurological diseases; state-of-the-art. Biotechnol Prog. 2023:e3363.

Hamade DF, Epperly MW, Fisher R, Hou W, Shields D, van Pijkeren J-P, Leibowitz BJ, Coffman LG, Wang H, M Huq S, et al. Genetically Engineered Probiotic Releasing IL-22 (LR-IL-22) Modifies the Tumor Microenvironment, Enabling Irradiation in Ovarian Cancer. Cancers (Basel). 2024;16(3).

Wenzel M, Aquadro CF. genetically interacts with the germline stem cell gene in male . MicroPubl Biol. 2023;2023.

Mundra V, Wu H, Mahato RI. Genetically modified human bone marrow derived mesenchymal stem cells for improving the outcome of human islet transplantation. PLoS One. 2013;8(10):e77591.

Kumagai G, Tsoulfas P, Toh S, McNiece I, Bramlett HM, W Dietrich D. Genetically Modified Mesenchymal Stem Cells (MSCs) promote axonal regeneration and prevent hypersensitivity after Spinal Cord Injury. Exp Neurol. 2013.

Bahrambeigi V, Ahmadi N, Salehi R, Javanmard SHaghjooy. Genetically Modified Murine Adipose-Derived Mesenchymal Stem Cells Producing Interleukin-2 Favors B16F10 Melanoma Cell Proliferation. Immunol Invest. 2015:1-21.

Jung G, Sun J, Petrowitz B, Riecken K, Kruszewski K, Jankowiak W, Kunst F, Skevas C, Richard G, Fehse B, et al. Genetically Modified Neural Stem Cells for a Local and Sustained Delivery of Neuroprotective Factors to the Dystrophic Mouse Retina. Stem Cells Transl Med. 2013.

Wang X, Liu T-X, Zhang Y, Xu L-W, Yuan S-L, Cui A-L, Guo W-W, Wang Y-F, Yang S-M, Zhao J-G. Genetically modified pigs: Emerging animal models for hereditary hearing loss. Zool Res. 2024;45(2):284-291.

Price CJ, Stavish D, Gokhale PJ, Stevenson BA, Sargeant S, Lacey J, Rodríguez TA, Barbaric I. Genetically variant human pluripotent stem cells selectively eliminate wild-type counterparts through YAP-mediated cell competition. Dev Cell. 2021.

Teque F, Ye L, Xie F, Wang J, Morvan MG, Kan YWai, Levy JA. Genetically-edited iPSCs derived from HIV-1 infected patients on therapy can give rise to immune cells resistant to HIV-1 infection. AIDS. 2020.

Ovchinnikov DA. Genetically-modified cell lines: categorisation and considerations for characterisation. Stem Cell Res. 2020;49:102103.

Ding SLee Shirle, Koh AEe-Hwan, Kumar S, Khan MSafwan Ali, Alzahrani B, Mok PLing. Genetically-modified human mesenchymal stem cells to express erythropoietin enhances differentiation into retinal photoreceptors: An in-vitro study. J Photochem Photobiol B. 2019;195:33-38.

Awwad HAl-Deen M, Thiagarajan L, Kanczler JM, Amer MH, Bruce G, Lanham S, Rumney RMH, Oreffo ROC, Dixon JE. Genetically-programmed, mesenchymal stromal cell-laden & mechanically strong 3D bioprinted scaffolds for bone repair. J Control Release. 2020.

Stacey SN, Zink F, Halldorsson GH, Stefansdottir L, Gudjonsson SA, Einarsson G, Hjörleifsson G, Eiriksdottir T, Helgadottir A, Björnsdottir G, et al. Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis. Nat Genet. 2023.

Narayan P, Richter F, Morton S. Genetics and etiology of congenital heart disease. Curr Top Dev Biol. 2024;156:297-331.

Jung C, Evans MA, Walsh K. Genetics of age-related clonal hematopoiesis and atherosclerotic cardiovascular disease. Curr Opin Cardiol. 2020.

Prytkova I, Goate A, Hart RP, Slesinger PA. Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells?. Alcohol Clin Exp Res. 2018.

Wang S, Kang Y, Qi F, Jin H. Genetics of Hair Graying With Age. Ageing Res Rev. 2023:101977.

Story CMcIlwaine, Wang T, Bhatt VRaj, Battiwalla M, Badawy SM, Kamoun M, Gragert L, Brown V, Baxter-Lowe LAnn, Marsh SGe, et al. Genetics of HLA peptide presentation, and impact on outcomes in HLA-matched allo-HCT. Transplant Cell Ther. 2021.

Pages